/ /

Oncology

New era looming MCC treatmentImmune checkpoint inhibitors are providing rapid and durable responses for patients with metastatic Merkel cell carcinoma.
Diagnosing melanomaNewer tools to help diagnose challenging lesions include combined immunohistochemical stains and a growing array of genetic tests, one of which has shown the potential to gauge metastatic risk.
Responding to melanoma’s growing threatMelanoma’s burden is increasing and the rising rates cannot simply be attributed to increased disease detection, according to a research letter published last month in JAMA Dermatology.
World-wide skin cancer epidemiologyThe incidence of melanoma appears to be on the rise except for that observed in the younger population, underscoring a positive trend and hope for the fight against skin cancer.
Update on advanced basal cell carcinoma diagnosis and treatmentDespite increased insight on skin cancer risk factors, the incidence continues to rise worldwide. This review article summarizes new treatment options available, which help to redefine and expand the diagnosis of advanced BCC and allow dermatologists to offer more effective therapy to a broader population.
Clinical acumen key for identifying pediatric melanomaExperts discuss diagnosis and management of pediatric melanoma, including the latest developments in genetic tools and indications for sentinel lymph node biopsy.
Staying current with therapeutic advances and expert insightsThis month we offer new insights and data to aid diagnosis and treatment of difficult conditions, as well as practical approaches to optimize outcomes.
CeraVe sun protection products earn recommendation sealsCeraVe AM Facial Moisturizing Lotion SPF 30 and CeraVe Sunscreen SPF 50 for Face (both by Valeant Pharmaceuticals) have been awarded Skin Cancer Foundation seals.
Best practices for treating severe sun damageThe goal of treatment for severely sun-damaged patients’ lesions is field therapy, which not only treats what dermatologists see, but also subclinical disease.
Vismodegib study confirms safety, efficacy for BCCThe largest-ever vismodegib study in advanced basal cell carcinoma, the STEVIE study, confirms pivotal study findings in a real-world setting, helping dermatologists to provide a complete palette of skin cancer treatments.

Poll

View Results